VICCGI0906 Phase Ib Trial of Gemcitabine and Oxaliplatin (GEMOX) with Erlotinib in Patients with Advanced Biliary Tract Cancer.
Phase of Trial: Phase I
Latest Information Update: 06 Jul 2017
At a glance
- Drugs Erlotinib (Primary) ; Gemcitabine; Oxaliplatin
- Indications Biliary cancer; Duodenal cancer; Pancreatic cancer
- Focus Adverse reactions
- 29 Jun 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 16 Nov 2016 Results analysing safety published in the Investigational New Drugs.